帕金森病中注射用阿扑吗啡与口服左旋多巴 - Suppr

Suppr

超能文献

Injected apomorphine and orally administered levodopa in Parkinsonism.

作者信息

Düby S E, Cotzias G C, Papavasiliou P S, Lawrence W H

出版信息

Arch Neurol. 1972 Dec;27(6):474-80. doi: 10.1001/archneur.1972.00490180010004.

DOI:10.1001/archneur.1972.00490180010004

PMID:4563448

Abstract

摘要

相似文献

Injected apomorphine and orally administered levodopa in Parkinsonism.帕金森病中注射用阿扑吗啡与口服左旋多巴

Arch Neurol. 1972 Dec;27(6):474-80. doi: 10.1001/archneur.1972.00490180010004.

Unexpected findings with apomorphine and their possible consequences.阿扑吗啡的意外发现及其可能的后果。

Adv Neurol. 1974;5:295-9.

N Engl J Med. 1970 Jan 1;282(1):31-3. doi: 10.1056/NEJM197001012820107.

Levodopa and orphenadrine hydrochloride in Parkinsonism.

Eur J Clin Pharmacol. 1971 Dec;4(1):18-21. doi: 10.1007/BF00568893.

Combined L-dopa and amantadine in Parkinsonism.左旋多巴与金刚烷胺联合治疗帕金森病

Aust N Z J Med. 1972 Aug;2(3):252-5. doi: 10.1111/j.1445-5994.1972.tb03070.x.

Augmenting the action of levodopa.增强左旋多巴的作用。

Postgrad Med J. 1972 Nov;48(565):653-6. doi: 10.1136/pgmj.48.565.653.

MK 486 and levodopa in treatment of Parkinsonism.

Dis Nerv Syst. 1973 Apr-May;34(4):167-71.

Levodopa therapy effects on natural history of Parkinsonism.

Arch Neurol. 1972 Dec;27(6):481-5. doi: 10.1001/archneur.1972.00490180017005.

Evaluation of Levodopa for Parkinsonism. Levodopa (Dopar, Larodopa).

JAMA. 1971 Mar 22;215(12):1969-72. doi: 10.1001/jama.1971.03180250061016.

Ro 4-4602 and levodopa in the treatment of Parkinsonism.

Neurology. 1974 May;24(5):482-6. doi: 10.1212/wnl.24.5.482.

引用本文的文献

Intermittent Apomorphine Use for off Period Rescue in Parkinson's Disease: A Pragmatic Review of over Three Decades of Clinical Experience.间歇性使用阿扑吗啡用于帕金森病“关”期急救：对三十多年临床经验的实用综述

Mov Disord Clin Pract. 2022 Oct 27;10(2):190-208. doi: 10.1002/mdc3.13593. eCollection 2023 Feb.

In Parkinson's patient-derived dopamine neurons, the triplication of α-synuclein locus induces distinctive firing pattern by impeding D2 receptor autoinhibition.在帕金森病患者来源的多巴胺神经元中，α-突触核蛋白基因三重复导致 D2 受体自身抑制受阻，从而诱导出独特的放电模式。

Acta Neuropathol Commun. 2021 Jun 7;9(1):107. doi: 10.1186/s40478-021-01203-9.

Old Drugs, New Delivery Systems in Parkinson's Disease.帕金森病的老药新剂型

Drugs Aging. 2019 Sep;36(9):807-821. doi: 10.1007/s40266-019-00682-9.

The Many Faces of Apomorphine: Lessons from the Past and Challenges for the Future.阿朴吗啡面面观：从过去的经验教训到未来的挑战。

Drugs R D. 2018 Jun;18(2):91-107. doi: 10.1007/s40268-018-0230-3.

Pharmacological Insights into the Use of Apomorphine in Parkinson's Disease: Clinical Relevance.阿扑吗啡在帕金森病中的应用的药理学研究进展：临床相关性。

Clin Drug Investig. 2018 Apr;38(4):287-312. doi: 10.1007/s40261-018-0619-3.

The management of orthostatic hypotension in Parkinson's disease.帕金森病直立性低血压的管理。

Front Neurol. 2013 Jun 10;4:64. doi: 10.3389/fneur.2013.00064. eCollection 2013.

Subcutaneous apomorphine : an evidence-based review of its use in Parkinson's disease.皮下注射阿扑吗啡：关于其在帕金森病中应用的循证综述

Drugs Aging. 2004;21(11):687-709. doi: 10.2165/00002512-200421110-00001.

Continuous subcutaneous waking day apomorphine in the long term treatment of levodopa induced interdose dyskinesias in Parkinson's disease.持续皮下注射阿扑吗啡用于帕金森病左旋多巴诱导的剂末异动症的长期治疗

J Neurol Neurosurg Psychiatry. 1998 May;64(5):573-6. doi: 10.1136/jnnp.64.5.573.

Pen injected apomorphine against off phenomena in late Parkinson's disease: a double blind, placebo controlled study.笔式注射阿扑吗啡治疗晚期帕金森病的“剂末现象”：一项双盲、安慰剂对照研究

J Neurol Neurosurg Psychiatry. 1995 Jun;58(6):681-7. doi: 10.1136/jnnp.58.6.681.

Increased growth hormone response to dopamine infusion in insulin-dependent diabetic subjects: indication of possible blood-brain barrier abnormality.胰岛素依赖型糖尿病患者对多巴胺输注的生长激素反应增强：提示可能存在血脑屏障异常。

J Clin Invest. 1980 Jan;65(1):146-53. doi: 10.1172/JCI109644.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验